Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cationic Nanoparticle-Mediated Activation of Natural Killer Cells for Effective Cancer Immunotherapy
Dong Hwan Kim, Jun‐Hyeok Han, Seung Hee Choi, et al.
ACS Applied Materials & Interfaces (2020) Vol. 12, Iss. 51, pp. 56731-56740
Closed Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Natural killer cell homing and trafficking in tissues and tumors: from biology to application
Guanghe Ran, Yu qing Lin, Lei Tian, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 147
Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
Qiang Lü, Dongquan Kou, Shenghan Lou, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 131
NK cell-based tumor immunotherapy
Hao Zhang, Yang Li, Tingting Wang, et al.
Bioactive Materials (2023) Vol. 31, pp. 63-86
Open Access | Times Cited: 44
Evidence and therapeutic implications of biomechanically regulated immunosurveillance in cancer and other diseases
Vincent Mittelheisser, Valentin Gensbittel, Lucia Bonati, et al.
Nature Nanotechnology (2024) Vol. 19, Iss. 3, pp. 281-297
Closed Access | Times Cited: 25
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
Man Wang, Fei Yu, Yuan Zhang
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Nanotechnology-enhanced immunotherapy for metastatic cancer
Peisen Zhang, Junli Meng, Yingying Li, et al.
The Innovation (2021) Vol. 2, Iss. 4, pp. 100174-100174
Open Access | Times Cited: 69
Chitosan–Hyaluronic Acid Nanoparticles for Active Targeting in Cancer Therapy
Lisa Efriani Puluhulawa, I Made Joni, Khaled M. Elamin, et al.
Polymers (2022) Vol. 14, Iss. 16, pp. 3410-3410
Open Access | Times Cited: 43
Engineering nanomaterial physical characteristics for cancer immunotherapy
DaeYong Lee, Kristin Huntoon, Jacques Lux, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 7, pp. 499-517
Closed Access | Times Cited: 36
Cationic nanocarriers: A potential approach for targeting negatively charged cancer cell
Monika Vishwakarma, Poornima Agrawal, Sakshi Soni, et al.
Advances in Colloid and Interface Science (2024) Vol. 327, pp. 103160-103160
Closed Access | Times Cited: 12
Enhancing CAR‐NK Cells Against Solid Tumors Through Chemical and Genetic Fortification with DOTAP‐Functionalized Lipid Nanoparticles
Ha Eun Shin, Jun‐Hyeok Han, Joo Dong Park, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 30
Closed Access | Times Cited: 10
Chitosan and hyaluronic acid in breast cancer treatment: Anticancer efficacy and nanoparticle and hydrogel development
Yanlin Jiang, Yu Cao, Yiqun Yao, et al.
International Journal of Biological Macromolecules (2025) Vol. 301, pp. 140144-140144
Closed Access | Times Cited: 1
Magneto-Activation and Magnetic Resonance Imaging of Natural Killer Cells Labeled with Magnetic Nanocomplexes for the Treatment of Solid Tumors
Taehoon Sim, Bongseo Choi, Soon Woo Kwon, et al.
ACS Nano (2021) Vol. 15, Iss. 8, pp. 12780-12793
Closed Access | Times Cited: 51
Enhanced natural killer cell anti-tumor activity with nanoparticles mediated ferroptosis and potential therapeutic application in prostate cancer
Dong Hwan Kim, Bongseo Choi, Hyunjun Choi, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 37
Charge-switchable nanoparticles enhance Cancer immunotherapy based on mitochondrial dynamic regulation and immunogenic cell death induction
Ming Zhao, Ji Li, Jingwen Liu, et al.
Journal of Controlled Release (2021) Vol. 335, pp. 320-332
Closed Access | Times Cited: 34
Targeting the innate immune system with nanoparticles for cancer immunotherapy
Kai Li, Zhicheng Zhang, Yu Mei, et al.
Journal of Materials Chemistry B (2022) Vol. 10, Iss. 11, pp. 1709-1733
Closed Access | Times Cited: 23
Polymeric biomaterial-inspired cell surface modulation for the development of novel anticancer therapeutics
Ashok Kumar Jangid, Sung Jun Kim, Kyobum Kim
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 15
Recent Advances to Augment NK Cell Cancer Immunotherapy Using Nanoparticles
Dong Hwan Kim, Dong‐Hwan Kim, Dong‐Hyun Kim
Pharmaceutics (2021) Vol. 13, Iss. 4, pp. 525-525
Open Access | Times Cited: 27
Natural killer cell therapy: A new frontier for obesity-associated cancer
Eimear Mylod, Joanne Lysaght, Melissa J. Conroy
Cancer Letters (2022) Vol. 535, pp. 215620-215620
Open Access | Times Cited: 21
Nanoparticle Enhancement of Natural Killer (NK) Cell-Based Immunotherapy
Dhanashree Murugan, Vasanth Murugesan, Balaji Panchapakesan, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5438-5438
Open Access | Times Cited: 19
Progress in nanoparticle-based regulation of immune cells
Ya-Nan Fan, Gui Zhao, Yue Zhang, et al.
Medical Review (2023) Vol. 3, Iss. 2, pp. 152-179
Open Access | Times Cited: 12
Nano-chemical priming strategy to enhance TGF-β resistance and anti-tumor activity of natural killer cells
Seung Hee Choi, Hui Bang Cho, Jin‐Ho Choi, et al.
Journal of Controlled Release (2024) Vol. 367, pp. 768-778
Closed Access | Times Cited: 4
Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment
Natasha Mupeta Kaweme, Fuling Zhou
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 24
Nanobiomaterials to modulate natural killer cell responses for effective cancer immunotherapy
Aun Raza, Gustavo Rodrigues Rossi, Taskeen Iqbal Janjua, et al.
Trends in biotechnology (2022) Vol. 41, Iss. 1, pp. 77-92
Closed Access | Times Cited: 18
Nanoparticle-Mediated Immunotherapy in Triple-Negative Breast Cancer
Ruoyi Wang, Xu Huang, Xiaoxi Chen, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 6, pp. 3568-3598
Open Access | Times Cited: 3
The basic biology of NK cells and its application in tumor immunotherapy
Pan Jiang, Shaoze Jing, Gaohong Sheng, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top